Roche presented these findings at the 2025 San Antonio Breast Cancer Symposium (SABCS). ... biotech and science. He can be reached at tristan ...
News
- Roche's Oral SERD Cuts Death Risk by 30% in Early-Stage Breast Cancer - BioSpace
- Celcuity Presents Updated Results from the PIK3CA Wild-Type Cohort of the Phase ... - StreetInsider
The additional study results were presented in an oral presentation session at the 2025 San Antonio Breast Cancer Symposium (“SABCS”) today, Thursday, ...
- ADC Post-Endocrine Therapy Misses Mark in Advanced Breast Cancer Trial
SAN ANTONIO -- The antibody-drug conjugate (ADC) sacituzumab govitecan ... Biotechnology. Lathrop had no relevant financial disclosures ...
- Intensity Therapeutics, Inc. to Present Two Posters at the 2025 San Antonio Breast Cancer ...
... San Antonio Breast Cancer Symposium ("SABCS"), in San Antonio, TX being held at the Henry B. Gonzalez Conven.
- Preoperative radiation may improve antitumor immune response in most common form of ...
Biomedical technology · Cardiology · Dentistry · Diabetes · Diseases ... San Antonio Breast Cancer Symposium (SABCS), held December 9–12, 2025 ...